<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Murugan K</submitter><funding>Ministry of Science and Technology, Taiwan</funding><funding>Center of Excellence for Ocean Engineering, NTOU, Taiwan</funding><pagination>4765</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8933857</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(1)</volume><pubmed_abstract>Mosquito borne diseases are on the rise because of their fast spread worldwide and the lack of effective treatments. Here we are focusing on the development of a novel anti-malarial and virucidal agent with biocidal effects also on its vectors. We have synthesized a new quinoline (4,7-dichloroquinoline) derivative which showed significant larvicidal and pupicidal properties against a malarial and a dengue vector and a lethal toxicity ranging from 4.408 µM/mL (first instar larvae) to 7.958 µM/mL (pupal populations) for Anopheles stephensi and 5.016 µM/mL (larva 1) to 10.669 µM/mL (pupae) for Aedes aegypti. In-vitro antiplasmodial efficacy of 4,7-dichloroquinoline revealed a significant growth inhibition of both sensitive strains of Plasmodium falciparum with IC&lt;sub>50&lt;/sub> values of 6.7 nM</pubmed_abstract><journal>Scientific reports</journal><pubmed_title>Synthesis of new series of quinoline derivatives with insecticidal effects on larval vectors of malaria and dengue diseases.</pubmed_title><pmcid>PMC8933857</pmcid><funding_grant_id>MOST 109-2621-M-019-002</funding_grant_id><funding_grant_id>109J13801-51</funding_grant_id><funding_grant_id>MOST 110-2621-M-019-001</funding_grant_id><funding_grant_id>110J13801-51</funding_grant_id><funding_grant_id>MOST 108-2621-M-019-003</funding_grant_id><pubmed_authors>Hwang JS</pubmed_authors><pubmed_authors>Portilla-Pulido JS</pubmed_authors><pubmed_authors>Mendez SC</pubmed_authors><pubmed_authors>Paulpandi M</pubmed_authors><pubmed_authors>Aziz AT</pubmed_authors><pubmed_authors>Rajaganesh R</pubmed_authors><pubmed_authors>Vasanthakumaran M</pubmed_authors><pubmed_authors>Shafi SS</pubmed_authors><pubmed_authors>Dinesh D</pubmed_authors><pubmed_authors>Wang L</pubmed_authors><pubmed_authors>Duque JE</pubmed_authors><pubmed_authors>Murugan K</pubmed_authors><pubmed_authors>Madhavan J</pubmed_authors><pubmed_authors>Panneerselvam C</pubmed_authors><pubmed_authors>Subramaniam J</pubmed_authors><pubmed_authors>Roni M</pubmed_authors><pubmed_authors>Chandramohan B</pubmed_authors><pubmed_authors>Piramanayagam S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Synthesis of new series of quinoline derivatives with insecticidal effects on larval vectors of malaria and dengue diseases.</name><description>Mosquito borne diseases are on the rise because of their fast spread worldwide and the lack of effective treatments. Here we are focusing on the development of a novel anti-malarial and virucidal agent with biocidal effects also on its vectors. We have synthesized a new quinoline (4,7-dichloroquinoline) derivative which showed significant larvicidal and pupicidal properties against a malarial and a dengue vector and a lethal toxicity ranging from 4.408 µM/mL (first instar larvae) to 7.958 µM/mL (pupal populations) for Anopheles stephensi and 5.016 µM/mL (larva 1) to 10.669 µM/mL (pupae) for Aedes aegypti. In-vitro antiplasmodial efficacy of 4,7-dichloroquinoline revealed a significant growth inhibition of both sensitive strains of Plasmodium falciparum with IC&lt;sub>50&lt;/sub> values of 6.7 nM</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-05-31T22:58:40.98Z</modification><creation>2024-11-11T23:08:13.431Z</creation></dates><accession>S-EPMC8933857</accession><cross_references><pubmed>35306526</pubmed><doi>10.1038/s41598-022-08397-5</doi></cross_references></HashMap>